Suzuken Co., Ltd. (TYO:9987)

Suzuken Revenue

Suzuken had revenue of 628.96B JPY in the quarter ending June 30, 2026, with 6.09% growth. This brings the company's total for the last twelve months to 2.52T, up 4.65% year-over-year. In the fiscal year ending March 31, 2026, Suzuken had annual revenue of 2.49T with 3.61% growth. That makes Suzuken the 948th largest company in the world by revenue and 90th in Japan.

• Revenue (ttm): 2.52T
• Revenue Growth: +4.65%
• P/S Ratio: 0.15
• Revenue / Employee: 198.38M
• Employees: 12,717
• Market Cap: 404.34B

Revenue Chart

Chart

Chart

Revenue by Segment

Chart

• Pharmaceutical Distribution 2.40T 79.4%
• Specialty Drug Contract Distribution Business 436.10B 14.4%
• Community Healthcare and Nursing Care Support Business 93.94B 3.1%
• Healthcare Product Development 51.64B 1.7%
• Healthcare Related Services 42.96B 1.4%

Fiscal year ended Mar 31, 2026 See the full Suzuken breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Mar 31, 2026	2.49T	86.70B	3.61%
Mar 31, 2025	2.40T	13.46B	0.56%
Mar 31, 2024	2.39T	71.67B	3.10%
Mar 31, 2023	2.31T	82.05B	3.67%
Mar 31, 2022	2.23T	104.56B	4.91%

Data Source: S&P Global Market Intelligence Last updated: Aug 7, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 23, 2026

Data Sources Report a data error